Despite the fact that electronic pacemakers are life-saving medical devices, their long-term performance in pediatric patients can be problematic owing to the restrictions imposed by a child's small size and their inevitable growth. Consequently, there is a genuine need for innovative therapies designed specifically for pediatric patients with cardiac rhythm disorders. We propose that a conductive biological alternative consisting of a collagen-based matrix containing autologously-derived cells could better adapt to growth, reduce the need for recurrent surgeries, and greatly improve the quality of life for these patients. In the present study, we describe a procedure for incorporating primary skeletal myoblast cell cultures within a hydrogel matrix to fashion a surgically-implantable tissue construct that will serve as an electrical conduit between the upper and lower chambers of the heart. Ultimately, we anticipate using this type of engineered tissue to restore atrioventricular electrical conduction in children with complete heart block. In view of that, we isolate myoblasts from the skeletal muscles of neonatal Lewis rats and plate them onto laminin-coated tissue culture dishes using a modified version of established protocols [2, 3] . After one to two days, cultured cells are collected and mixed with antibiotics, type 1 collagen, Matrigel™, and NaHCO3. The result is a viscous, uniform solution that can be cast into a mold of nearly any shape and size [1, 4, 5] . For our tissue constructs, we employ type 1 collagen isolated from fetal lamb skin using standard procedures [6] . Once the tissue has solidified at 37°C, culture media is carefully added to the plate until the construct is submerged. The engineered tissue is then allowed to further condense through dehydration for 2 more days, at which point it is ready for in vitro assessment or surgical-implantation.
. A solidified myoblast-containing tissue construct [1] . Figure 3 . H&E stained sections of a myoblast-containing tissue construct. "A" depicts a longitudinal section and "B" shows a cross-section.
Discussion
The molds in which the tissue construct will be cast can be made in any shape and size; however, there needs to be at least two points of attachment. Otherwise, the matrix and cells form a spherical structure and the cells die. In the present protocol, we describe the use of a polyester mesh for this purpose, yet we have also successfully used stainless steel mesh. Obviously, larger molds will require more cells and a larger volume of the other ingredients. When making the molds, it is important to minimize the amount of silicone adhesive used and to ensure that it is located at the very ends of the tubing. This is because myoblasts near the adhesive tend not to be viable, even after several days of curing. In addition, it is prudent to plate the myoblasts for only a day or two before preparing the tissue constructs as contaminating fibroblasts will multiply rapidly and eventually overwhelm the myogenic components of the culture. Similarly, myoblasts should not be plated densely because cells in contact with one another will begin to fuse and differentiate into myotubes. In regard to the fabrication of the tissue constructs, there are a number of commercially available sources of type 1 collagen; however, each demonstrate differences in the rate of solidification and the consistency of the final product. Furthermore, it is essential that the collagen preparation is not irradiated with UV light as this process inhibits the gelation process. In our hands, the constructs change color from a dark pink to a light pink during solidification. Finally, our collagen preparation is acid-solublized (not pepsin digested), so the pH of the mixture in step 3.5 needs to be increased by adding NaHCO3 before incorporating the cells.
